|
Using Promega MAPK Antibodies and Reagents to Study
Signaling in Neurons
Reviewed by Yi Wu, Ph.D., Promega Corporation
The authors investigated the role of MAPK signaling in
controlling activity-dependent morphological changes in dendritic spines.
Anti-ACTIVE® MAPK pAb, the inhibitors U0126 and PD98059, and BDNF
were obtained from Promega.
PDF article (77kb)
Neural Notes Home
|
